PT  - JOURNAL ARTICLE
AU  - Abdulaziz S. Aldawood
AU  - Roman Jaeschke
TI  - Use of antiplatelets and lipid lowering therapy in patients with peripheral vascular disease
DP  - 2002 May 01
TA  - Saudi Medical Journal
PG  - 585--588
VI  - 23
IP  - 5
4099  - http://smj.org.sa/content/23/5/585.short
4100  - http://smj.org.sa/content/23/5/585.full
SO  - Saudi Med J2002 May 01; 23
AB  - OBJECTIVE: To investigate the use of antiplatelet and lipid lowering therapy among patients undergoing peripheral vascular surgery, and to compare their use with that reported among a similar population of patients in Canada.METHODS: Chart review of a cohort of 52 patients undergoing peripheral vascular surgery. The study was carried out at King Fahad National Guard Hospital, Kingdom of Saudi Arabia in May 2000.RESULTS: On discharge, less than 50% of the patients received any antiplatelet or antithrombotic medication. Only 13% of the patients received lipid-lowering therapy. Those findings parallel those of Canadian publications.CONCLUSION: Current literature supports the use of anti platelet and lipid-lowering therapy among patients with peripheral vascular disease. In King Fahad Hopsital, National Guard, Kingdom of Saudi Arabia, the use of those beneficial interventions is likely sub-optimal. Factors other than randomized clinical trail derived evidence likely influence practice and behavior. Whether dissemination of evidence may change such a pattern of behavior requires further study.